At a glance
ClinicalIndex Comparison RecordN/ACompleted· 69 enrolled
Drug / intervention
Systane Balance +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Efficacy of an Ocular Emulsion on the Signs and Symptoms of Meibomian Gland Dysfunction
Southern California College of Optometry at Marshall B. Ketchum University·interventional·Posted Sep 23, 2010·Updated Apr 1, 2025
In Brief
A clinical study evaluating Systane Balance and Optive Lubricant Eye Drops for Meibomian Gland Dysfunction. Completed, enrolled 69 participants across 1 site.
Detailed Summary
The aim of this study will be to determine the efficacy of this novel, lipid-containing artificial tear on the signs and symptoms of meibomian gland disease.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMeibomian Gland Dysfunction
CountriesUnited States
CollaboratorsAlcon Research
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2010
First PostedSep 2010
Primary CompletionJul 2011
TodayJul 2026
First PostedSep 23, 2010
Enrollment StartSep 1, 2010
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 15.8 years ago
Interventions
Systane Balancedrug
Artificial tear emulsion drop
Optive Lubricant Eye Dropsdrug
Artificial tear eye drop